Market Cap (In CNY)
17.83 Billion
Revenue (In CNY)
13.24 Billion
Net Income (In CNY)
318.97 Million
Avg. Volume
3.23 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 14.15-19.7
- PE
- -
- EPS
- -
- Beta Value
- 0.517
- ISIN
- CNE100002FV6
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Chao Zhao
- Employee Count
- -
- Website
- https://www.buchang.com
- Ipo Date
- 2016-11-18
- Details
- Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China. Shandong Buchang Pharmaceuticals Co., Ltd. was a former subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.
More Stocks
-
AAUGFAngold Resources Ltd.
AAUGF
-
CMRBCMR, S.A.B. de C.V.
CMRB
-
7038
-
603096Thinkingdom Media Group Ltd.
603096
-
CRTMCritical Metals Plc
CRTM
-
IRS-WT
-
BAMBINOBambino Agro Industries Limited
BAMBINO
-
NHCFOODSNHC Foods Limited
NHCFOODS